American Association of Equine Practitioners
American Association of Equine Practitioners

Parasite Control Guidelines HEADING_TITLE

Commonly used strategies for parasite control in adult horses are based largely on knowledge and concepts that are more than 40 years old. However, much has changed in this time, necessitating a re-examination of recommendations for parasite control.

In response to this need, the AAEP’s Parasite Control Subcommittee of the Infectious Disease Committee has produced a comprehensive set of recommendations for helping veterinarians develop improved strategies and programs for parasite control in horses of all ages.

It is important to keep in mind that the information contained within these guidelines are suggestions; there are many variations of these suggested programs that will still meet the same goals and follow the same principles. Ultimately, each farm (with veterinary guidance) should develop its own program tailored to the specific needs of the farm and each animal. There is no such thing as a “one size fits all” program.

Guidelines are specified separately for adult and young horses (less than 3 years). All treatment and non-treatment recommendations are made within the context of a preventive program where fecal egg count (FEC) surveillance is being performed.

Read Parasite Control Guidelines.

  • Parasite Control Guidelines WebinarClick to Expand

    Parasite Control Guidelines Webinar: Putting New Strategies to Work in Your Practice

    The AAEP held a webinar on May 15, 2013, led by Dr. Martin Nielsen of the University of Kentucky's Gluck Equine Research Center about the association's Parasite Control Guidelines. During his talk he covered the current status of anthelmintic resistance, how to generate and interpret parasite surveillance data, the smart application of available anthelmintic formulations, and the specific control recommendations for foals, young horses and adults.
    *Please note: when the presentation first opens, you will be asked to enter your name and contact information.
    At the end of his presentation, Dr. Nielsen answered questions from webinar attendees, which have been transcribed to a FAQ here.